SEC 13F Intelligence

Ophir Asset Management Pty Ltd / ADMA

Ophir Asset Management Pty Ltd’s Adma Biologics Inc Position

Does Ophir Asset Management Pty Ltd own Adma Biologics Inc (ADMA)? Not currently — the last reported position was 1.26M shares worth $18M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$18M
Q3 2025
Shares
1.26M
% of Portfolio
+2.27%
Quarters Held
7
position exited

Position History ADMA

Reported value by quarter
Q1 ’24: $23MQ1 ’24Q2 ’24: $20MQ2 ’24Q3 ’24: $15MQ3 ’24Q4 ’24: $23MQ4 ’24Q1 ’25: $23MQ1 ’25Q2 ’25: $23MQ2 ’25Q3 ’25: $18MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20251.26M$18M+2.27%
Q2 20251.22M$23M+3.61%
Q1 20251.16M$23M+4.02%
Q4 20241.34M$23M+3.43%
Q3 2024763.1K$15M+2.35%
Q2 20241.83M$20M+3.63%
Q1 20243.43M$23M+3.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ophir Asset Management Pty Ltd’s full portfolio or all institutional holders of ADMA.